Quarterly ResultMay 5, 2026, 04:40 PM
LeMaitre Vascular Q1 Sales $66.6M (+11%), EPS $0.68 (+42%)
AI Summary
LeMaitre Vascular reported strong Q1 2026 financial results, with sales increasing 11% to $66.6 million and diluted EPS growing 42% to $0.68. The company also announced a quarterly dividend of $0.25 per share and provided increased guidance for Q2 and the full year 2026, projecting continued sales and EPS growth. Additionally, a $100 million share repurchase program remains active.
Key Highlights
- Q1 2026 sales reached $66.6 million, an 11% increase (10% organic) year-over-year.
- Diluted EPS for Q1 2026 was $0.68, up 42% compared to Q1 2025.
- Gross margin improved by 350 basis points to 72.7%, with operating income up 41% to $17.8 million.
- Cash increased sequentially by $8.1 million to $367.2 million.
- Board approved a quarterly dividend of $0.25 per share, payable June 4, 2026.
- Full year 2026 sales guidance raised to $277-$283 million (midpoint $280 million, +12% organic).
- Full year 2026 adjusted EPS guidance increased to $2.93-$3.08 (midpoint $3.00, +26%).
- Artegraft sales grew 36% worldwide, with EMEA (+20%), APAC (+18%), and Americas (+7%) posting record sales.